These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10082277

  • 1. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
    Kula NS, Tarazi FI, Baldessarini RJ, Xu L, Bakthavachalam V, Pounds S, True CD.
    Eur J Pharmacol; 1999 Feb 12; 367(1):139-42. PubMed ID: 10082277
    [Abstract] [Full Text] [Related]

  • 2. RBI-257: a highly potent dopamine D4 receptor-selective ligand.
    Kula NS, Baldessarini RJ, Kebabian JW, Bakthavachalam V, Xu L.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):333-6. PubMed ID: 9274997
    [Abstract] [Full Text] [Related]

  • 3. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Langenegger D, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1999 Oct 23; 128(3):613-20. PubMed ID: 10516640
    [Abstract] [Full Text] [Related]

  • 4. Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor.
    Schlachter SK, Poel TJ, Lawson CF, Dinh DM, Lajiness ME, Romero AG, Rees SA, Duncan JN, Smith MW.
    Eur J Pharmacol; 1997 Mar 19; 322(2-3):283-6. PubMed ID: 9098699
    [Abstract] [Full Text] [Related]

  • 5. Binding of [3H]U-101958 to sigma1 receptor-like sites in human cerebellum and neuroblastoma cells.
    Helmeste DM, Shioiri T, Mitsuhashi M, Tang SW.
    Eur J Pharmacol; 1999 Apr 09; 370(2):205-9. PubMed ID: 10323271
    [Abstract] [Full Text] [Related]

  • 6. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1998 Jul 09; 124(5):889-96. PubMed ID: 9692773
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina.
    Patel S, Chapman KL, Marston D, Hutson PH, Ragan CI.
    Neuropharmacology; 2003 Jun 09; 44(8):1038-46. PubMed ID: 12763097
    [Abstract] [Full Text] [Related]

  • 8. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW.
    J Pharmacol Exp Ther; 1997 Aug 09; 282(2):1020-7. PubMed ID: 9262371
    [Abstract] [Full Text] [Related]

  • 9. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, Curtis NR, Kulagowski JJ, Freedman SB.
    Mol Pharmacol; 1996 Dec 09; 50(6):1658-64. PubMed ID: 8967990
    [Abstract] [Full Text] [Related]

  • 10. Selective alkylatation of dopamine D2 and D4 receptors in rat brain by N-(p-isothiocyanatophenethyl)spiperone.
    Zhang K, Tarazi FI, Kula NS, Baldessarini RJ, Neumeyer JL.
    Neurosci Lett; 1999 Oct 29; 274(3):155-8. PubMed ID: 10548413
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart.
    Ricci A, Bronzetti E, Fedele F, Ferrante F, Zaccheo D, Amenta F.
    J Auton Pharmacol; 1998 Apr 29; 18(2):115-21. PubMed ID: 9730266
    [Abstract] [Full Text] [Related]

  • 12. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T.
    Br J Pharmacol; 1996 Apr 29; 117(8):1625-32. PubMed ID: 8732269
    [Abstract] [Full Text] [Related]

  • 13. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 29; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 14. Is clozapine selective for the dopamine D4 receptor?
    Durcan MJ, Rigdon GC, Norman MH, Morgan PF.
    Life Sci; 1995 Jul 29; 57(18):PL275-83. PubMed ID: 7475902
    [Abstract] [Full Text] [Related]

  • 15. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB, Terranova MA, Chang R, Uchic ME, Matulenko MA, Surber BW, Stewart AO, Brioni JD.
    Eur J Pharmacol; 2004 Aug 23; 497(2):147-54. PubMed ID: 15306199
    [Abstract] [Full Text] [Related]

  • 16. Use of [3H]-clozapine as a ligand of the dopamine D4 receptor subtype in peripheral tissues.
    Ricci A, Bronzetti E, Rossodivita I, Amenta F.
    J Auton Pharmacol; 1997 Aug 23; 17(4):261-7. PubMed ID: 9373785
    [Abstract] [Full Text] [Related]

  • 17. Regional distribution of dopamine D4 receptors in rat forebrain.
    Tarazi FI, Kula NS, Baldessarini RJ.
    Neuroreport; 1997 Nov 10; 8(16):3423-6. PubMed ID: 9427299
    [Abstract] [Full Text] [Related]

  • 18. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M, Cowart MD, Hsieh GC, Miller L, Uchic ME, Chang R, Terranova MA, Donnelly-Roberts DL, Namovic MT, Miller TR, Wetter JM, Marsh K, Stewart AO, Brioni JD, Moreland RB.
    Neuropharmacology; 2005 Jul 10; 49(1):112-21. PubMed ID: 15992586
    [Abstract] [Full Text] [Related]

  • 19. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA, Chu A, Sibley DR.
    J Pharmacol Exp Ther; 1999 May 10; 289(2):956-64. PubMed ID: 10215675
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
    Lahti RA, Evans DL, Stratman NC, Figur LM.
    Eur J Pharmacol; 1993 Jun 04; 236(3):483-6. PubMed ID: 8102973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.